Ethics approval and consent to participate
Cancer
FARBER, CANCER
The study was performed in accordance with ethical principles that have their origin in the Declaration of Helsinki and are consistent with the International Conference on Harmonisation (ICH)/Good Clinical Practice (GCP) guidelines, applicable regulatory requirements, and the AstraZeneca policy on Bioethics and Human Biological Samples. The study protocol and all modifications were approved by relevant ethics committees or institutional review boards: IntegReview, Austin, TX; MD Anderson IRB, Houston, TX; Dana Farber Cancer Institute IRB, Boston, MA; WIRB, Puyallup, WA. All patients provided written informed consent.